Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

Research To Practice | Oncology Videos · Nov 30, 2022 · 1h 3m

Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:

PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00)

Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03)

Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09)

Tumor Treating Fields (41:35)

PARP Inhibitor Update (47:29)

CME information and select publications